News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
RTW INVESTMENTS, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 5.1% stake in C4 Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6% stake in Tenaya Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 5.6% stake in Jounce Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.8% stake in ASLAN Pharmaceuticals Limited |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.5% stake in Pyxis Oncology, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.5% stake in Macrogenics, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.6% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.5% stake in Immunic, Inc. |
| 12/15/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/03/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.7% stake in Cutera, Inc. |
| 07/29/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 12.9% stake in Chardan Healthcare Acquisition 2 Corp. |
| 07/02/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.5% stake in ESSA Pharma Inc. |
| 05/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/17/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 8.8% stake in Prometheus Biosciences, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.3% stake in Frequency Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 5.4% stake in Vincerx Pharma, Inc. |
| 02/16/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 6.6% stake in * Lifesci Acquisition II Corp. |
| 02/16/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 5.7% stake in FIVE PRIME THERAPEUTICS, INC. |
| 02/04/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.9% stake in iTeos Therapeutics Inc. |
| 01/22/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.2% stake in IDEAYA Biosciences, Inc. |
| 12/03/2020 |
SC 13G
| RTW INVESTMENTS, LP reports a 10% stake in Cogent Biosciences, Inc. |
| 11/16/2020 |
SC 13G
| RTW INVESTMENTS, LP reports a 9% stake in Aptevo Therapeutics Inc. |
| 11/13/2020 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.6% stake in Fulcrum Therapeutics, Inc. |
| 10/26/2020 |
SC 13G
| RTW INVESTMENTS, LLC reports a 12.8% stake in Tarsus Pharmaceuticals, Inc. |
| 09/28/2020 |
SC 13G
| RTW INVESTMENTS, LLC reports a 8.7% stake in Athira Pharma, Inc. |
| 06/29/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/19/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/11/2020 |
SC 13G
| RTW INVESTMENTS, LLC reports a 8.3% stake in Relmada Therapeutics, Inc. |
|
|
|